• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • From foreign- to China-made medical devices

From foreign- to China-made medical devices

Thursday, 12 March 2020 / Published in Medical Device, News

From foreign- to China-made medical devices

On 05.03.2020, the China NMPA (National Medical Products Administration) has launched a public consultation concerning the transfer of NMPA certificates of imported Class II and Class III medical devices and IVDs to a domestic enterprise for manufacturing in China. This measure would encourage foreign manufacturers to localize their approved medical devices in China in future.

According to the proposed regulation, the NMPA is simplifying the procedure for foreign enterprises to re-register their products – which must have initially been approved as an imported device – in order to claim their medical devices as domestically made in China. As hospital public tenders encourage domestic made products, foreign companies could benefit from this faster and easier way of relocating medical devices from overseas manufacturing sites to China sites once the announcement is officially implemented.
Since there is a great market potential for the medical device industry in China, the registration system and the quality standards are expected to continue to make significant improvements.

China NMPA will continue to solicit public opinions until 31.03.2020. Please provide your opinions to us before the deadline so we can submit a strong submission to the NMPA together.

Tagged under: China-made, foreign-made, medical device

What you can read next

China clinical trials gcp
China Clinical Trials GCP – Important Changes for the Administration of Medical Device & IVD Clinical Trials
Webinar China Cosmetics
Webinar: China Cosmetics Ingredient Code Submission
China Adjusts Import Tariff of Medical Devices

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.